Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
97%
Diseases
67%
COVID-19
43%
Biological Marker
39%
N(g),n(g) Dimethylarginine
39%
Arginine
37%
Rheumatoid Arthritis
37%
Inflammatory Arthritis
37%
Artery Compliance
34%
Lymphocyte
32%
Blood Pressure
27%
Idiopathic Pulmonary Fibrosis
27%
Hypertension
25%
Community-Acquired Pneumonia
25%
Frailty
25%
Inflammation
25%
Neutrophil
23%
Comorbidity
23%
Platelet
21%
Hospital Mortality
19%
Radial Artery
19%
Metabolite
17%
Polypharmacy
17%
Malignant Neoplasm
16%
Diabetes Mellitus
16%
Adverse Outcome
16%
Cardiovascular Risk
16%
Oxidative Stress
15%
Meta-Regression
15%
Body Mass Index
14%
Area under the Curve
14%
Nitric Oxide
14%
Cardiovascular System
13%
Risk Stratification
13%
Odds Ratio
13%
Chronic Obstructive Pulmonary Disease
13%
Logistic Regression Analysis
13%
Quality of Life
12%
Coronavirinae
12%
Geriatric Assessment
12%
Homoarginine
12%
Latent Class Analysis
12%
Prevalence
11%
Parasympatholytic
11%
Femoral Artery
11%
Ergothioneine
11%
Dimethylargininase
11%
Adverse Effect
10%
Hazard Ratio
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
56%
N(g),n(g) Dimethylarginine
54%
6 N,n' Dimethylarginine
54%
Inflammatory Arthritis
44%
Rheumatoid Arthritis
44%
Arginine
38%
Diseases
37%
Dimethylargininase
34%
Pharmacokinetic
32%
Methotrexate
31%
Cholinergic Receptor Blocking Agent
27%
Cardiovascular Risk
26%
Inflammation
25%
Malignant Neoplasm
24%
Non-Steroidal Anti-Inflammatory Drug
24%
Polypharmacy
24%
Frailty
23%
Atherosclerosis
22%
Biological Marker
20%
Clinical Trial
20%
Nitric Oxide
20%
Adverse Drug Reaction
20%
Congestive Heart Failure
18%
Enzyme
18%
Hypertension
18%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Homocysteine
16%
Cardiovascular Disease
15%
Adverse Effect
15%
Fibrosing Alveolitis
14%
Thiol
14%
Proton Pump Inhibitor
14%
Clinical Pharmacology
14%
Observational Study
13%
Life Expectancy
13%
Placebo
12%
Prevalence
12%
All Cause Mortality
12%
Antioxidant
11%
Comorbidity
11%
Vasculotropin
11%
Pharmaceutical Chemistry
11%
Malonaldehyde
11%
Cholesterol
11%
Endothelial Dysfunction
10%
Cohort Study
10%
Pharmacodynamics
10%
Statin (Protein)
9%
Morbidity
9%
Folic Acid
9%
Immunology and Microbiology
Inflammatory Arthritis
79%
COVID-19
59%
Rheumatic Disease
46%
Lymphocyte
43%
Cardiovascular System
40%
Inflammation
37%
Oxidative Stress
36%
Neutrophil
35%
Arginine
30%
Medline
28%
Platelet
28%
Systemic Inflammation
27%
Albumin
27%
Scopus
27%
Web of Science
26%
Blood Plasma
24%
Blood Pressure
21%
Coronavirinae
20%
Methotrexate
20%
Prevalence
19%
Systemic Scleroderma
18%
Metabolite
15%
Atherosclerosis
14%
Blood Cell Count
14%
C-Reactive Protein
14%
Vasculotropin
14%
Hospital Mortality
12%
Infectious Disease
12%
Infection
12%
Blood Level
12%
Homocysteine
11%
Red Blood Cell Distribution Width
11%
Arterial Stiffness
11%
Lung
10%
Body Mass
9%
Homeostasis
8%
Psoriatic Arthritis
8%
Systemic Lupus Erythematosus
8%
Neopterin
8%
Cell Adhesion Proteins
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Monocyte
8%
Erythrocyte
7%
Comorbidity
7%
Tryptophan
7%
Superoxide Dismutase
7%
P-Selectin
6%
Cellular Distribution
6%
Serum (Blood)
6%
Pulse Wave
6%